About 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine
4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine (PubChem CID 139359017) has the molecular formula C18H17BrN8O
and a molecular weight of 441.29 g/mol. Its IUPAC name is 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine.
Molecular Properties
| Compound Name | 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine |
| PubChem CID | 139359017 |
| Molecular Formula | C18H17BrN8O |
| Molecular Weight | 441.29 g/mol |
| Exact Mass | 440.07 |
| IUPAC Name | 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine |
| SMILES | CC1C(c2cn[nH]c2)OCCN1c1ccnc(-c2cnc3cnc(Br)cn23)n1 |
| InChI | InChI=1S/C18H17BrN8O/c1-11-17(12-6-23-24-7-12)28-5-4-26(11)15-2-3-20-18(25-15)13-8-22-16-9-21-14(19)10-27(13)16/h2-3,6-11,17H,4-5H2,1H3,(H,23,24) |
| InChIKey | AZPUKLQQRHYQIG-UHFFFAOYSA-N |
| XLogP | 2.64 |
| TPSA | 97.12 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 441.29 |
| LogP ≤ 5 | 2.64 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine?
The IUPAC name of 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine (CID 139359017) is 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine.
What is the SMILES notation for 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine?
The canonical SMILES for 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine is CC1C(c2cn[nH]c2)OCCN1c1ccnc(-c2cnc3cnc(Br)cn23)n1.
What is the InChIKey of 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine?
The InChIKey is AZPUKLQQRHYQIG-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H17BrN8O/c1-11-17(12-6-23-24-7-12)28-5-4-26(11)15-2-3-20-18(25-15)13-8-22-16-9-21-14(19)10-27(13)16/h2-3,6-11,17H,4-5H2,1H3,(H,23,24).
What are the key properties of 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine?
4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine has a molecular weight of 441.29 g/mol, XLogP of 2.64, 3 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-(6-bromoimidazo[1,2-a]pyrazin-3-yl)pyrimidin-4-yl]-3-methyl-2-(1H-pyrazol-4-yl)morpholine is sourced from PubChem (CID 139359017), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).